Caricamento...
The impact of body weight on rivaroxaban pharmacokinetics
ESSENTIALS: The optimal dosing strategy of rivaroxaban for patients at the extremes of body weight is not known. A pharmacokinetic study was conducted based in real‐world patients in a London teaching hospital. In the cohort of patients studied, weight on its own did not impact significantly on riva...
Salvato in:
| Pubblicato in: | Res Pract Thromb Haemost |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6058267/ https://ncbi.nlm.nih.gov/pubmed/30046688 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12039 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|